Accumulating data from preclinical and experimental studies also support that melatonin may have beneficial effects on insulin signaling, adipocyte differentiation, and lipid metabolism in obesity, as well as inflammation in diabetes and related comorbidities [6,7,8,9]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.